Oncology Precision Medicine Market Size
Market Size in USD Bn
CAGR9.00%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 9.00% |
| Market Concentration | High |
| Major Players | AstraZeneca, Novartis, Pfizer, Bristol-Myers Squibb, Roche and Among Others |
please let us know !
Oncology Precision Medicine Market Analysis
The Global Oncology Precision Medicine Market is estimated to be valued at USD 153.81 billion in 2025 and is expected to reach USD 281.17 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.00% from 2025 to 2032. Precision oncology focuses on therapies and diagnostics tailored for each patient's specific genes, environment, and lifestyle. The approach analyzes a patient's genetic makeup and matches them with available targeted therapies.
The market is expected to witness significant growth due to rising prevalence of cancer worldwide and increasing application of personalized medicine in oncology. Furthermore, advancements in genomics and availability of companion diagnostic tests are helping doctors provide customized treatment plans based on a deep understanding of an individual patient's tumor biology. Continuous research into understanding cancer at molecular level will further drive adoption of precision oncology practices.